Neoadjuvant (primary systemic) treatment has become a standard option for primary
operable disease for patients who are candidates for adjuvant systemic chemotherapy …

Purpose The clinical diagnosis and management of invasive lobular carcinoma (ILC) of the
breast presents difficulties. Magnetic resonance imaging (MRI) has been proposed as the …

Visualization in Medicine is the first book on visualization and its application to problems in
medical diagnosis, education, and treatment. The book describes the algorithms, the …

Background. The therapeutic resistance of pancreatic ductal adenocarcinoma (PDAC) is
partly ascribed to ineffective delivery of chemotherapy to cancer cells. We hypothesized that …

Neoadjuvant chemotherapy has become the standard treatment for patients with locally
advanced breast cancer; however a technique that can accurately differentiate responders …

Dynamic contrast‐enhanced MRI (DCE‐MRI) is an evolving tool for determining breast
disease, which benefits from the move to imaging at 3 T. It has major capabilities for the …

Purpose. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) allows
analysis of both tumor volume and contrast enhancement pattern using a single tool. We …

Background Neoadjuvant chemotherapy (NAC) is the standard of care for patients with
locally advanced breast cancer (LABC). The study was conducted to investigate the utility of …

A prospective study was undertaken in women undergoing neoadjuvant chemotherapy for
locally advanced breast cancer in order to determine the ability of quantitative magnetic …

Purpose The purpose of this pilot study is to determine (1) if early changes in both
semiquantitative and quantitative DCE‐MRI parameters, observed after the first cycle of …